Come and join us across the globe
I just came back from SVIN 2025 in Orlando after four intense days that felt like a full snapshot of where neurointervention is heading—strong science, real-world practicality, and a clear push toward innovation and global impact.
One of the most meaningful moments for me was the CREST-2 presentation by Dr. James Meschia. You could feel the room’s attention shift, because this isn’t just “another trial.” This is one of those moments that you will remember that shifted our practice.
SVIN also leaned hard into the future. The congress didn’t just talk about innovation—it funded it, with a $150,000 grant this year awarded to Sonobrain, which was a strong signal that new ideas can find support and momentum here. That innovation theme was also reflected in the techniques being discussed. A great example: the continued evolution of transvascular treatment strategy for chronic subdural hematoma—a technique that could also change the future management of the disease and open a whole new area for neurointervention.
On the clinical side, the program was consistently strong. There were excellent sessions and discussions across AVMs, aneurysms, stroke, and DAVFs—updates that were practical, experience-based, and immediately “take-home” for everyday decision-making.
A very important part of the meeting, was MT2020+. It brought the spotlight to something that sometimes is forget in high-resource settings: the reality of stroke care around the world. Hearing different experiences (what’s possible, what’s not, and how teams are building thrombectomy systems in developing countries) was both motivating and grounding. It reframed “progress” as not only new devices and new data, but also implementation, training, access, and system design.
Overall, SVIN 2025 felt like a meeting that balanced the best of both worlds: high-level evidence that will shape the field, and real-life stories and solutions that shape patient care today.
Reported by Rodrigo Rivera
